Articles written by Jeremy Golden - Benzinga

Would you like to be notified of the latest news and updates on the stock market?

You can disable these notifications through your browser settings.

Calibre Mining (OTC: CXBMF) Uses Artificial Intelligence To Push Gold Mining Operations Forward

Sponsored

Candel Therapeutics' (NASDAQ: CADL) enLIGHTEN Discovery Platform Aims To Tackle Complexities Of Tumor Microenvironments

Sponsored

Candel Therapeutics' (NASDAQ: CADL) Lead Candidate CAN-2409 Combats Lung, Pancreatic And Prostate Cancers With Fast Track Designation For Three Cancers

Sponsored

Candel Therapeutics (NASDAQ: CADL) Reports Positive Data From Phase 2 Trial Of CAN-2409 In Borderline Resectable Pancreatic Cancer

Sponsored

New Study Shows Cardio Diagnostics' (NASDAQ: CDIO) PrecisionCHD Test Could Save Health Insurers Over $113 Million Annually

Sponsored

3 Trends In Healthcare Guided By AI And The Companies Behind The Innovation

Sponsored

The Growing Market Demand For Waste Energy Solutions And How Sky Quarry Has Prepared Itself To Meet It

Sponsored

Cardio Diagnostics Inks Groundbreaking Telehealth Agreement With Navierre And Expands Access To Cardiovascular Tests

Sponsored

Elicio Therapeutics (NASDAQ: ELTX) Makes Strides In Growing Cancer Vaccination Industry

Sponsored

Unlocking The Power Of Immunotherapy: Elicio Therapeutics' (NASDAQ: ELTX) Novel AMP Platform

Sponsored

Helping Build A Sustainable Future For Construction Materials – Sky Quarry's Innovative Approach To Recycling Shingles, Recovering Oil

Sponsored

Candel Therapeutics (NASDAQ: CADL) Lead Product Candidate CAN-3110 Demonstrates Promise To Treat Deadly Brain Tumors

Sponsored

Syra Health (NASDAQ: SYRA) Wins $650,000 Healthcare Quality Improvement Contract

Sponsored

Sky Quarry Is Paving The Way Toward A Potential Solution For The Multi-Billion Dollar Waste Asphalt Shingle Problem

Sponsored

Innoveren Scientific's (OTCMKTS: IVRN) 510(k) Submission Sparks A New Hope For Patients Living With Chronic Non-Healing Wounds

Sponsored

Oncolytics Biotech (NASDAQ: ONCY) (TSX: ONC) Fights Cancer With Pelareorep, Which Has Received FDA Fast Track Designation For Breast And Pancreatic Cancer

Sponsored

Moving Fast: Candel's (NASDAQ: CADL) CAN-3110 Granted FDA Fast Track Designation For Recurrent High-Grade Glioma Following Fast Track Designation For CAN-2409 In Pancreatic Cancer

Sponsored

Enlivex Receives Regulatory Authorization From Israel's Health Ministry For The Initiation Of Phase 1/2 Trial Evaluating Allocetra In Patients With Knee Osteoarthritis

Sponsored

Enlivex Completes Enrollment Of All 120 Patients In Phase 2 Trial Of Allocetra In Patients With Sepsis, Third-Leading Cause Of Mortality In US Hospitals

Sponsored

Cardio Diagnostics (NASDAQ: CDIO) Expands Partnership With Family Medicine Specialists To Bring Specialty Cardiology Tests To Select Walmart Supercenters

A precision cardiovascular medicine company’s innovative AI-driven epigenetic-genetic blood tests will soon be available in one of the nation’s largest retailers.

Sponsored